• ALDH2 Activation Delays Pressure-Overload Heart Failure

  2026-08-28

  The reference study identifies ALDH2 as a regulator of cardiomyocyte proliferation, showing that its activation extends the early postnatal proliferative window and improves outcomes in adult mice exposed to ventricular pressure overload. These findings connect aldehyde metabolism with cardiac regeneration and provide a framework for evaluating ALDH2 activation in cardiac disease models.

• CENPI Drives Breast Cancer Through Wnt/β-Catenin

  2026-08-28

  The 2025 Cancer Cell International study identifies centromere protein I (CENPI) as an overexpressed breast cancer driver linked to progression and poor prognosis. By combining clinical datasets, cellular and xenograft models, RNA sequencing, and pathway reporter assays, the authors connect CENPI activity to Wnt/β-catenin signaling and provide a mechanistic framework for further biomarker and therapeutic research.

• Iguratimod Prodrug Rewires RA Synovial Crosstalk

  2026-08-27

  A 2026 study identifies TYK2 JH2-dependent control of STAT1 as a mechanism through which iguratimod suppresses rheumatoid arthritis fibroblast-like synoviocyte invasiveness. It also reveals a STAT1–C3–TNF-α feedback loop linking synovial fibroblasts with macrophages and introduces the oral prodrug AD811 as a pharmacokinetic strategy for retaining iguratimod activity in collagen-induced arthritis.

• ROS-Responsive Nanotherapy for Diabetic Periodontitis

  2026-08-27

  The reference study develops a hierarchically targeted, ROS-responsive hydrogel that delivers mitoquinone to M1 macrophages and repairs mitochondrial dysfunction in diabetic periodontitis. Its reported effects include suppression of NLRP3 inflammasome signaling, reduced inflammatory injury, and improved alveolar bone regeneration, although translational questions about dosing, safety, and clinical comparators remain.

• QSHXO, Autophagy, and Ferroptosis in MASLD

  2026-08-26

  A 2026 World Journal of Hepatology study shows that Qushi Huoxue ointment reduces hepatic lipid accumulation and inflammatory injury in an MCD diet-induced mouse model of MASLD. Its main contribution is a coordinated mechanistic model in which enhanced autophagy and Nrf2-associated suppression of ferroptosis contribute to hepatocyte protection.

• Annexin V-Cy5 Apoptosis Kit for Microglia

  2026-08-26

  Use the Annexin V-Cy5 Apoptosis Kit to distinguish phosphatidylserine exposure and apoptosis from the non-apoptotic lysosomal stress described in a zebrafish microglia model. Its 10-minute staining workflow supports complementary flow cytometry apoptosis detection and fluorescence microscopy apoptosis analysis.

• Ricin-Triggered Lung Necroptosis and Bystander Inflammation

  2026-08-25

  The reference study shows that ricin-injured monocytic cells can kill neighboring A549 lung epithelial cells through soluble mediators, converting a toxin-triggered donor response into recipient necroptosis. Its sequential supernatant-transfer design identifies residual ricin, FasL, and HMGB1–RAGE-associated ROS as contributors, while cautioning that ROS alone does not establish ferroptosis.

• Annexin V-Cy5 Apoptosis Kit for Microglial Stress

  2026-08-25

  Use the Annexin V-Cy5 Apoptosis Kit to distinguish apoptosis from lysosomal dysfunction in microglia, including reversible mestranol-stress models. Its rapid Cy5 readout supports both imaging and flow cytometry, adding a direct phosphatidylserine endpoint to phagocytosis, lysosomal, and transcriptomic studies.

• Flubendazole Workflows for Autophagy Research

  2026-08-24

  Build reproducible autophagy experiments around a DMSO-soluble benzimidazole compound, with practical guidance for dose finding, pathway readouts, and storage. A breast cancer extracellular-vesicle study provides a useful framework for connecting autophagy modulation with tumor-cell communication without overstating what the reference directly proves.

• Endothelial SGK1 Drives Vascular Stiffening

  2026-08-24

  Zhang and colleagues identify endothelial SGK1 as a mechanistic link between mineralocorticoid–salt exposure, endothelial sodium-channel activity, actin remodeling, and vascular stiffening. By combining endothelial-specific genetics with DOCA–salt mice and human aortic endothelial-cell experiments, the study provides a practical framework for evaluating SGK1 inhibition in hypertension research.

• BRD4–RAC1 Co-Targeting in Breast Cancer

  2026-08-23

  The reference study identifies combined BRD4 and RAC1 inhibition as a subtype-spanning strategy that suppresses breast cancer growth, stemness, migration, and xenograft tumorigenesis. Its mechanistic contribution is the linkage of BRD4–RAC1 signaling to the c-MYC–G9a–FTH1 axis and HDAC1-associated chromatin regulation, providing a framework for testing epigenetic dependencies in breast cancer.

• Tofacitinib Repairs RA Macrophage Dysfunction

  2026-08-22

  A 2026 study identifies GM-CSF-reprogrammed rheumatoid arthritis macrophages as an inflammatory and metabolically disturbed cell state marked by oxidative stress and mitochondrial fragmentation. It shows that Tofacitinib reverses this phenotype more broadly than metabolic comparator interventions by reducing GM-CSFRα expression, suppressing STAT5 signaling, and restoring regulatory and mitochondrial features.

• SU6656: Platelet Engineering and Radiotherapy

  2026-08-22

  SU6656 connects two practical research workflows: improving megakaryocyte polyploidization during hiPSC-derived platelet production and probing Src-dependent vascular responses to irradiation. This guide separates findings demonstrated in the 2026 differentiation study from pilot conditions for evaluating the compound as a small-molecule Src inhibitor.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-21

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection on immunoblots. It is intended for HRP-based Western blot workflows and should not be substituted into fluorescent or radioisotopic detection protocols.

• Hyperthermia Sensitizes BRCA2-Proficient Ovarian Cancer

  2026-08-20

  Mei et al. show that hyperthermia can reduce BRCA2 protein and increase niraparib sensitivity in ovarian carcinoma cells that retain BRCA2 function. The study links this effect to impaired RAD51 focus formation, enhanced apoptosis, tumor suppression, and prolonged survival in a syngeneic mouse model.

8007 records 1/534 page Next 12345 下5页 Last page